<?xml version="1.0" encoding="UTF-8"?>
<p>Therefore, the SARS-CoV-2 virus has a high level of identity with SARS-CoV. This suggests that an anti-SARS-CoV antibody, which could cross-react with the SARS-CoV-2 S protein, may be useful to treat patients with the virus.</p>
